Identification of endocrine disrupting chemicals acting on human aromatase

Biochim Biophys Acta Proteins Proteom. 2018 Jan;1866(1):88-96. doi: 10.1016/j.bbapap.2017.05.013. Epub 2017 Jun 1.

Abstract

Human aromatase is the cytochrome P450 catalysing the conversion of androgens into estrogens playing a key role in the endocrine system. Due to this role, it is likely to be a target of the so-called endocrine disrupting chemicals, a series of compounds able to interfere with the hormone system with toxic effects. If on one side the toxicity of some compounds such as bisphenol A is well known, on the other side the toxic concentrations of such compounds as well as the effect of the many other molecules that are in contact with us in everyday life still need a deep investigation. The availability of biological assays able to detect the interaction of chemicals with key molecular targets of the endocrine system represents a possible solution to identify potential endocrine disrupting chemicals. Here the so-called alkali assay previously developed in our laboratory is applied to test the effect of different compounds on the activity of human aromatase. The assay is based on the detection of the alkali product that forms upon strong alkali treatment of the NADP+ released upon enzyme turnover. Here it is applied on human aromatase and validated using anastrozole and sildenafil as known aromatase inhibitors. Out of the small library of compounds tested, resveratrol and ketoconazole resulted to inhibit aromatase activity, while bisphenol A and nicotine were found to exert an inhibitory effect at relatively high concentrations (100μM), and other molecules such as lindane and four plasticizers did not show any significant effect. These data are confirmed by quantification of the product estrone in the same reaction mixtures through ELISA. Overall, the results show that the alkali assay is suitable to screen for molecules that interfere with aromatase activity. As a consequence it can also be applied to other molecular targets of EDCs that use NAD(P)H for catalysis in a high throughput format for the fast screening of many different compounds as endocrine disrupting chemicals. This article is part of a Special Issue entitled: Cytochrome P450 biodiversity and biotechnology, edited by Erika Plettner, Gianfranco Gilardi, Luet Wong, Vlada Urlacher, Jared Goldstone.

Keywords: Alkali assay; Endocrine disrupting chemicals; Human aromatase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anastrozole
  • Aromatase / chemistry*
  • Aromatase / genetics
  • Aromatase Inhibitors / analysis
  • Aromatase Inhibitors / chemistry*
  • Benzhydryl Compounds / analysis
  • Benzhydryl Compounds / chemistry
  • Biological Assay*
  • Endocrine Disruptors / analysis
  • Endocrine Disruptors / chemistry*
  • Enzyme-Linked Immunosorbent Assay
  • Estrone / chemistry
  • Gene Expression
  • Humans
  • Ketoconazole / analysis
  • Ketoconazole / chemistry
  • Ligands
  • NADP / chemistry
  • Nicotine / analysis
  • Nicotine / chemistry
  • Nitriles / analysis
  • Nitriles / chemistry
  • Phenols / analysis
  • Phenols / chemistry
  • Protein Binding
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / genetics
  • Resveratrol
  • Sildenafil Citrate / analysis
  • Sildenafil Citrate / chemistry
  • Small Molecule Libraries / analysis
  • Small Molecule Libraries / chemistry
  • Stilbenes / analysis
  • Stilbenes / chemistry
  • Triazoles / analysis
  • Triazoles / chemistry

Substances

  • Aromatase Inhibitors
  • Benzhydryl Compounds
  • Endocrine Disruptors
  • Ligands
  • Nitriles
  • Phenols
  • Recombinant Proteins
  • Small Molecule Libraries
  • Stilbenes
  • Triazoles
  • Estrone
  • Anastrozole
  • NADP
  • Nicotine
  • Sildenafil Citrate
  • Aromatase
  • CYP19A1 protein, human
  • bisphenol A
  • Resveratrol
  • Ketoconazole